Latest filing published 16 Jan 2019 for Adaptimmune Therapeutics PLC, €7,094.
Filing timeline
BuySaleInsider track record
Gwendolyn Knowlton Binder-Scholl: trading record in brief
Gwendolyn Knowlton Binder-Scholl is a declared insider of Adaptimmune Therapeutics PLC, with filings sourced from SEC (Form 4). Between 29 August 2018 and 14 January 2019, the trades on record add up to 3 filings.
On the market, this insider has only sold: 3 sales, €524k in total. 2019 to date brings no purchases and 1 sale.
Most recently, on 16 January 2019, the filings show an open-market sale worth €7,094 in Adaptimmune Therapeutics PLC. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gwendolyn Knowlton Binder-Scholl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,514 shares@ US$5.371.4% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001104659-19-002166:0
- 25,000 shares@ US$13.7956.9% of flowAmerican Depositary SharesSEC:0001104659-18-060128:0
- 25,000 shares@ US$10.2541.8% of flowAmerican Depositary SharesSEC:0001104659-18-054853:0
3 of 3 declarations
